openPR Logo
Press release

Global Gemcitabine Hydrochloride Market 2016 - ChemWerth, Shilpa Medicare, FRESENIUS KABI, MSN Laboratories, ScinoPharm Taiwan, Shanghai Acebright, Fuan Pharmaceutical, JARI Pharmaceutical

11-22-2016 01:12 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fior Markets

Global Gemcitabine Hydrochloride Market 2016 - ChemWerth,

Gemcitabine is the hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine HCl is a clinically useful anticancer agent. It exerts its cytotoxic effects via the metabolites gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). dFdCTP is an inhibitor of DNA polymerase and is also incorporated in DNA strands resulting in termination of chain elongation and apoptosis. dFdCDP is an inhibitor of ribonucleotide reductase which results in depletion of deoxyribonucleotides needed for DNA synthesis. Gemcitabine metabolites have also been reported to inhibit cytidine triphosphate synthetase (CTP synthetase) and deoxycytidylate deaminase (dCMP deaminase).

Request for sample report at http://www.fiormarkets.com/report-detail/13621/request-sample

This report provides detailed analysis of worldwide markets for Gemcitabine Hydrochloride from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Gemcitabine Hydrochloride market and further lays out an analysis of the factors influencing the supply/demand for Gemcitabine Hydrochloride, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Global Gemcitabine Hydrochloride Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Gemcitabine Hydrochloride market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies.

Access full report at http://www.fiormarkets.com/report/global-gemcitabine-hydrochloride-market-outlook-2016-2021-13621.html

The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Gemcitabine Hydrochloride market are ChemWerth (USA), Shilpa Medicare (India), FRESENIUS KABI (India), MSN Laboratories (India), ScinoPharm Taiwan (Taiwan), Shanghai Acebright (China), Fuan Pharmaceutical (China), JARI Pharmaceutical (China), Chiatai Qingjiang (China), Luoxin Group (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Gemcitabine Hydrochloride industry has been provided.

Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry.

Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: sales@fiormarkets.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Gemcitabine Hydrochloride Market 2016 - ChemWerth, Shilpa Medicare, FRESENIUS KABI, MSN Laboratories, ScinoPharm Taiwan, Shanghai Acebright, Fuan Pharmaceutical, JARI Pharmaceutical here

News-ID: 385685 • Views: 358

More Releases from Fior Markets

Electric Boats and Ships Market 2019 Industry Dynamics - Akasol, Hinckley Yachts …
Recent market research study Global Electric Boats and Ships Market 2019-2024 now available with Fior Markets provides a comprehensive market analysis based on past and current situation of the market. The report covers future trends, current growth drivers, thoughtful insights, facts, market valuation, competitive spectrum, regional share, and revenue predictions. The report shows the market size, share, business growth enhancers, and obstructers, prior and current trends being followed by the
Automotive Service Market 2019 Industry Dynamics - Firestone Complete Auto Care, …
Recent market research study Global Automotive Service Market 2019-2024 now available with Fior Markets provides a comprehensive market analysis based on past and current situation of the market. The report covers future trends, current growth drivers, thoughtful insights, facts, market valuation, competitive spectrum, regional share, and revenue predictions. The report shows the market size, share, business growth enhancers, and obstructers, prior and current trends being followed by the market. The
Automotive and Transportation Connectors Market 2019 Industry Dynamics - TE Conn …
Recent market research study Global Automotive and Transportation Connectors Market 2019-2024 now available with Fior Markets provides a comprehensive market analysis based on past and current situation of the market. The report covers future trends, current growth drivers, thoughtful insights, facts, market valuation, competitive spectrum, regional share, and revenue predictions. The report shows the market size, share, business growth enhancers, and obstructers, prior and current trends being followed by the
Pet Veterinary Diets Market 2019 Industry Dynamics - Mars, Farmina Pet Foods, Ni …
Recent market research study Global Pet Veterinary Diets Market 2019-2024 now available with Fior Markets provides a comprehensive market analysis based on past and current situation of the market. The report covers future trends, current growth drivers, thoughtful insights, facts, market valuation, competitive spectrum, regional share, and revenue predictions. The report shows the market size, share, business growth enhancers, and obstructers, prior and current trends being followed by the market.

All 5 Releases


More Releases for Gemcitabine

Global Gemcitabine HCl Market 2019 | Sun Pharmaceutical Industries, Tapi Teva, S …
Market Research Hub (MRH) has actively included a new research study titled “Global Gemcitabine HCl Market” Research Report 2019 to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period 2019. In addition, a deep analysis
Global Bile Duct Cancer Drug Market Top Key Players: Delcath Systems Inc., Accor …
Zion Market Research has published a new report titled “Bile Duct Cancer Drug Market by Type (5-fluorouracil (5-FU), Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin, and Others) and by Application (Hospitals, Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”. According to the report, the global bile duct cancer drug market was valued at approximately USD 168 million in 2017 and is expected to generate revenue of around USD 262 million
Bile Duct Cancer Market Report 2018: Segmentation by Type (5-fluorouracil, Gemci …
Global Bile Duct Cancer market research report provides company profile for Teva Pharmaceutical, Eli Lilly and Company, Sanofi, Fresenius Kabi, Mylan, Pfizer, F. Hoffmann-La Roche, Bristol-Myers Squibb and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to
Global Gemcitabine Hydrochloride Market 2016 - ChemWerth, MSN Laboratories, Luox …
The report that is written on the title Gemcitabine Hydrochloride Market 2016 covers all the aspects of the global market study. This report has an estimation about the Gemcitabine Hydrochloride Market size in terms of value (US$). The report contains the broad segmentation of the market. The report provides the information about the Gemcitabine Hydrochloride Market and also forecasts its position in the coming years. Gemcitabine is the hydrochloride salt
2016-2021 Global Gemcitabine Hydrochloride Market Outlook – Market Research Hu …
Gemcitabine is the hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine HCl is a clinically useful anticancer agent. It exerts its cytotoxic effects via the metabolites gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). dFdCTP is an inhibitor of DNA polymerase and is also incorporated in DNA strands resulting in termination of chain elongation and apoptosis. dFdCDP is an inhibitor of ribonucleotide reductase which results
Global Gemcitabine Hydrochloride Market Outlook 2016-2021
Gemcitabine is the hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine HCl is a clinically useful anticancer agent. It exerts its cytotoxic effects via the metabolites gemcitabine diphosphate (dFdCDP) and gemcitabine triphosphate (dFdCTP). dFdCTP is an inhibitor of DNA polymerase and is also incorporated in DNA strands resulting in termination of chain elongation and apoptosis. dFdCDP is an inhibitor of ribonucleotide reductase which results